1. Home
  2. LMNR vs RNA Comparison

LMNR vs RNA Comparison

Compare LMNR & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$12.68

Market Cap

233.9M

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$12.98

Market Cap

217.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
RNA
Founded
1893
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
217.5M
IPO Year
2005
2025

Fundamental Metrics

Financial Performance
Metric
LMNR
RNA
Price
$12.68
$12.98
Analyst Decision
Strong Buy
Buy
Analyst Count
3
20
Target Price
$20.00
$69.26
AVG Volume (30 Days)
53.4K
340.0K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
2.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,723,000.00
N/A
Revenue This Year
N/A
$88.12
Revenue Next Year
$13.95
$18.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.20
$11.95
52 Week High
$17.11
$73.06

Technical Indicators

Market Signals
Indicator
LMNR
RNA
Relative Strength Index (RSI) 44.16 29.04
Support Level $12.54 $12.85
Resistance Level $13.60 $14.80
Average True Range (ATR) 0.39 0.65
MACD 0.01 0.74
Stochastic Oscillator 38.05 20.69

Price Performance

Historical Comparison
LMNR
RNA

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: